Wegovy, approved by the FDA in 2021 for weight loss, builds on Ozempic’s 2017 approval for type 2 diabetes. Both are GLP-1 receptor agonists but differ in dosage and use.
Many healthcare providers also recommend Wegovy for weight management based on their clinical expertise.